TISSUE MMP-7 EXPRESSION PREDICTS SURVIVAL IN BLADDER CANCER PATIENTS TREATED WITH CISPLATIN-BASED CHEMOTHERAPY

被引：2
|
作者：
Szarvas, Tibor
Kramer, Gero
Hess, Jochen
Tschirdewahn, Stephan
Reis, Henning
Romics, Imre
Sevcenco, Sabina
Toetsch, Martin
Ruebben, Herbert
Dorp, Frank Vom
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.1867
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1416
引用
收藏
页码：E575 / E575
页数：1
相关论文
共 50 条
  • [31] Survivin and ERCC-1 expression as prognostic factor for overall survival in patients with muscle-invasive bladder cancer with and without cisplatin-based chemotherapy
    Kiani, A.
    Kilic, E.
    Jung, K.
    Tervahartiala, M.
    Taimen, P.
    Bostroem, P. J.
    Gleichenhagen, J.
    Johnen, G.
    Pesch, B.
    Bruening, T.
    Blauhut, S.
    Rabien, A.
    Ecke, T. H.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (10) : 614 - 614
  • [32] STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer Patients
    Krafft, U.
    Tschirdewahn, S.
    Hess, J.
    Harke, N. N.
    Hadaschik, B. A.
    Nyirady, P.
    Szendroei, A.
    Szuecs, M.
    Modos, O.
    Olah, C.
    Szekely, E.
    Reis, H.
    Szarvas, Tibor
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (02) : 1243 - 1249
  • [33] The Glasgow Prognostic Score Predicts Poor Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma
    Chen, Cui
    Sun, Peng
    Dai, Qiang-sheng
    Weng, Hui-wen
    Li, He-ping
    Ye, Sheng
    PLOS ONE, 2014, 9 (11):
  • [34] Neoadjuvant cisplatin-based chemotherapy in patients with ureteral obstruction secondary to muscle invasive bladder cancer
    Strother, Marshall
    Kutikov, Alexander
    Lewis, Bianca
    Deng, Mengying
    Handorf, Elizabeth A.
    Epstein, Matthew
    Ghatalia, Pooja
    Greenberg, Richard E.
    Chen, David
    Viterbo, Rosalia
    Anari, Fern
    Smaldone, Marc C.
    Zibelman, Matthew R.
    Uzzo, Robert Guy
    Plimack, Elizabeth R.
    Geynisman, Daniel M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [35] Contemporary Use of Perioperative Cisplatin-Based Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
    Raj, Ganesh V.
    Karavadia, Saumil
    Schlomer, Bruce
    Arriaga, Yull
    Lotan, Yair
    Sagalowsky, Arthur
    Frenkel, Eugene
    CANCER, 2011, 117 (02) : 276 - 282
  • [36] Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy
    Grivas, Petros
    Bismar, Tarek A.
    Alva, Aijai S.
    Huang, Huei-Chung
    Liu, Yang
    Seiler, Roland
    Alimohamed, Nimira
    Cheng, Liang
    Hyndman, M. Eric
    Dabbas, Bashar
    Black, Peter C.
    Davicioni, Elai
    Wright, Jonathan L.
    Ornstein, Moshe C.
    Mian, Omar Y.
    Kaimakliotis, Hristos Z.
    Gibb, Ewan A.
    Lotan, Yair
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) : 262 - 268
  • [37] Concurrent cisplatin-based radiotherapy and chemotherapy improves survival of cervical cancer
    Dunst, J
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (06) : 257 - 258
  • [38] Thromboembolic events in metastatic testicular cancer treated with cisplatin-based chemotherapy
    Shields, Lisa B. E.
    Daniels, Michael W.
    Mar, Nataliya
    Rezazadeh Kalebasty, Arash
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (03): : 183 - 194
  • [39] Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
    Ota, Shuji
    Ishii, Genichiro
    Goto, Koichi
    Kubota, Kaoru
    Kim, Young Hak
    Kojika, Masakazu
    Murata, Yukinori
    Yamazaki, Manabu
    Nishiwaki, Yutaka
    Eguchi, Kenji
    Ochiai, Atsushi
    LUNG CANCER, 2009, 64 (01) : 98 - 104
  • [40] Cisplatin-based chemotherapy dramatically boosts survival in invasive cervical cancer
    不详
    FORMULARY, 1999, 34 (04) : 308 - 309
12345